Shantou Institute of Ultrasonic Instrument
301602
Hubei Sinophorus Electronic Materials
688545
Pansoft
300996
4
Jiayu Holding
300117
5
Wuxi Taclink Optoelectronics Technology
688205
US Stock MarketDetailed Quotes
SNY Sanofi
- 51.510
- -0.180-0.35%
Close Jan 22 16:00 ET
- 51.510
- 0.0000.00%
Post 16:03 ET
129.15BMarket Cap27.52P/E (TTM)
51.690High51.200Low1.84MVolume51.690Open51.690Pre Close94.38MTurnover0.08%Turnover Ratio22.98P/E (Static)2.51BShares58.97052wk High1.70P/B113.61BFloat Cap43.38152wk Low2.10Dividend TTM2.21BShs Float58.970Historical High4.07%Div YieldTTM0.95%Amplitude8.844Historical Low51.394Avg Price1Lot Size
About Sanofi Company
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Company Profile
SymbolSNY
Company NameSanofi
Founded1994
CEOMr. Paul Hudson
MarketNASDAQ
Employees87994
Securities TypeDR
ADS Ratio2.0 : 1.0
Fiscal Year Ends12-31
Address46, avenue de la Grande Armée
CityParis
ProvinceIle-de-France
CountryFrance
Zip Code75017
Phone33-1-53-77-40-00
Websitehttp://www.sanofi.com
Company Executives
- Name
- Position
- Salary
- Paul Hudson
- Director and Chief Executive Officer
- --
- Natalie Bickford
- Executive Vice President and Chief People Officer
- --
- Jean-Baptiste Chasseloup De Chatillon
- Executive Vice President and Chief Financial Officer
- --
- Emmanuel Frenehard
- Executive Vice President and Chief Digital Officer
- --
- Roy Papatheodorou
- Executive Vice President and General Counsel
- --
- Olivier Charmeil
- Executive Vice President, General Medicines
- --
- Houman Ashrafian
- Executive Vice President and Head of Research and Development
- --
- Madeleine Roach
- Executive Vice President, Business Operations
- --
- Thomas Triomphe
- Executive Vice President, Vaccines
- --
- Brendan O'Callaghan
- Executive Vice President, Global Manufacturing & Supply
- --
- Brian Foard
- Executive Vice President, Specialty Care
- --
- Julie Van Ongevalle
- Executive Vice President, Consumer Healthcare
- --
- Frederic Oudea
- Chairman of the Board
- --
- Christophe Babule
- Director
- --
- Barbara Lavernos
- Director
- --
- Yann Tran
- Director
- --
- Wolfgang Laux
- Director
- --
- Emile Voest
- Independent Director
- --
- Rachel Duan
- Independent Director
- --
- Dr. Antoine Yver, M.D.,M.Sc.
- Independent Director
- --
- Fabienne Lecorvaisier
- Independent Director
- --
- Thomas Sudhof
- Independent Director
- --
- Lise Kingo
- Independent Director
- --
- Patrick Kron
- Independent Director
- --
- Gilles Schnepp
- Independent Director
- --
- Diane Souza
- Independent Director
- --
- Carole Ferrand
- Independent Director
- --
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
December CPI comes in as expected, is that enough?
U.S. December CPI rose 2.9% year-on-year, aligning with expectations but marking a three-month inflation increase trend. The market reacted
In One Chart
Jan 15 22:05
Here's the Breakdown for December CPI, in One Chart